270 related articles for article (PubMed ID: 36588153)
1. Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development.
Gao L; Yang F; Tang D; Xu Z; Tang Y; Yang D; Sun D; Chen Z; Teng Y
J Exp Clin Cancer Res; 2023 Jan; 42(1):1. PubMed ID: 36588153
[TBL] [Abstract][Full Text] [Related]
2. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
[TBL] [Abstract][Full Text] [Related]
3. ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
Liu CC; Wang H; Wang WD; Wang L; Liu WJ; Wang JH; Geng QR; Lu Y
Cell Physiol Biochem; 2018; 46(4):1525-1535. PubMed ID: 29689546
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate Kinase Differentially Alters Metabolic Signatures during Head and Neck Carcinogenesis.
Huang PC; Chang CW; Lin YC; Chen CY; Chen TY; Chuang LT; Liu CJ; Huang CL; Li WC
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068962
[TBL] [Abstract][Full Text] [Related]
5. HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer.
Chen F; Tang C; Yang F; Ekpenyong A; Qin R; Xie J; Momen-Heravi F; Saba NF; Teng Y
Sci Adv; 2024 Feb; 10(8):eadk3663. PubMed ID: 38394204
[TBL] [Abstract][Full Text] [Related]
6. A Circular RNA, hsa_circ_0018180 (circPARD3), Triggers Glycolysis and Promotes Malignancy of Head and Neck Squamous Cell Carcinoma Through the miR-5194/ENO1 Axis.
Luo JT; Wang YF; Wang Y; Wang CL; Liu RY; Zhang Z
Biochem Genet; 2023 Feb; 61(1):316-335. PubMed ID: 35900705
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.
Zheng Y; Wu C; Yang J; Zhao Y; Jia H; Xue M; Xu D; Yang F; Fu D; Wang C; Hu B; Zhang Z; Li T; Yan S; Wang X; Nelson PJ; Bruns C; Qin L; Dong Q
Signal Transduct Target Ther; 2020 May; 5(1):53. PubMed ID: 32398667
[TBL] [Abstract][Full Text] [Related]
8. Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer.
Yukimoto R; Nishida N; Hata T; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Satoh T; Hirofumi Y; Mizushima T; Doki Y; Eguchi H
Cancer Sci; 2021 Jul; 112(7):2884-2894. PubMed ID: 33934428
[TBL] [Abstract][Full Text] [Related]
9. HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma.
Zhang H; Yin X; Zhang X; Zhou M; Xu W; Wei Z; Song C; Han S; Han W
Technol Cancer Res Treat; 2022; 21():15330338221118202. PubMed ID: 35929142
[No Abstract] [Full Text] [Related]
10. Regulation of SESAME-mediated H3T11 phosphorylation by glycolytic enzymes and metabolites.
Yu Q; Tong C; Luo M; Xue X; Mei Q; Ma L; Yu X; Mao W; Kong L; Yu X; Li S
PLoS One; 2017; 12(4):e0175576. PubMed ID: 28426732
[TBL] [Abstract][Full Text] [Related]
11. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
[TBL] [Abstract][Full Text] [Related]
12. PKM2 Modulation in Head and Neck Squamous Cell Carcinoma.
Boschert V; Teusch J; Müller-Richter UDA; Brands RC; Hartmann S
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054968
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of enolase 2 is associated with worsened prognosis and increased glycikolysis in papillary renal cell carcinoma.
Sun C; Liu M; Zhang W; Wang S; Qian G; Wang M; Zhang G
J Cell Physiol; 2021 May; 236(5):3821-3831. PubMed ID: 33135164
[TBL] [Abstract][Full Text] [Related]
14. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
15. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
Vander Heiden MG; Locasale JW; Swanson KD; Sharfi H; Heffron GJ; Amador-Noguez D; Christofk HR; Wagner G; Rabinowitz JD; Asara JM; Cantley LC
Science; 2010 Sep; 329(5998):1492-9. PubMed ID: 20847263
[TBL] [Abstract][Full Text] [Related]
17. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells.
Dey P; Kundu A; Sachan R; Park JH; Ahn MY; Yoon K; Lee J; Kim ND; Kim IS; Lee BM; Kim HS
Cell Physiol Biochem; 2019; 52(6):1535-1552. PubMed ID: 31135122
[TBL] [Abstract][Full Text] [Related]
18. Aurora A-mediated pyruvate kinase M2 phosphorylation promotes biosynthesis with glycolytic metabolites and tumor cell cycle progression.
Jiang Y; Wang T; Sheng D; Han C; Xu T; Zhang P; You W; Fan W; Zhang Z; Jin T; Duan X; Yuan X; Liu X; Zhang K; Ruan K; Shi J; Guo J; Cheng A; Yang Z
J Biol Chem; 2022 Nov; 298(11):102561. PubMed ID: 36198360
[TBL] [Abstract][Full Text] [Related]
19. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
20. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.
Yadav S; Bhagat SD; Gupta A; Samaiya A; Srivastava A; Shukla S
BMC Cancer; 2019 Nov; 19(1):1031. PubMed ID: 31675998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
